THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS

THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS

Библиографические подробности
Главные авторы:	Maddison, P, Titulaer, M, Verschuuren, J, Gozzard, P, Lang, B, Willcox, N, Vincent, A, Irani, SR, Chapman, C
Формат:	Conference item
Опубликовано:	2012

Схожие документы

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders
по: Maddison, P, и др.
Опубликовано: (2018)

Antibodies associated with paraneoplastic neurological disorders.
по: Vincent, A
Опубликовано: (2005)

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies
по: Cristina Arnaldos-Pérez, и др.
Опубликовано: (2023-05-01)

Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer.
по: Maddison, P, и др.
Опубликовано: (2008)

Paraneoplastic neurological syndromes: a practical approach to diagnosis and management
по: Binks, S, и др.
Опубликовано: (2021)

ANTI-HU PARANEOPLASTIC SENSORY NEURONOPATHY WITH UNDERLYING SQUAMOUS CELL CARCINOMA OF THE LUNG
по: Gozzard, P, и др.
Опубликовано: (2010)

Recommended diagnostic criteria for paraneoplastic neurological syndromes.
по: Graus, F, и др.
Опубликовано: (2004)

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.
по: Graus, F, и др.
Опубликовано: (2005)

Review: Progress in the management of paraneoplastic neurological disorders
по: Hamid Sadeghian, и др.
Опубликовано: (2010-01-01)

Paraneoplastic neurological syndromes. State of the art
по: Giometto, B, и др.
Опубликовано: (2006)

Paraneoplastic neurological syndromes
по: Antoine Jean-Christophe, и др.
Опубликовано: (2007-05-01)

Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations
по: Raquel Ruiz-García, и др.
Опубликовано: (2019-04-01)

N-methyl-d-aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
по: Irani, SR, и др.
Опубликовано: (2010)

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
по: Irani, SR, и др.
Опубликовано: (2010)

Diagnosis of paraneoplastic neurological syndromes
по: Camilo E Fadul MD
Опубликовано: (2007-07-01)

Diagnosis of paraneoplastic neurological syndromes
по: Camilo E Fadul MD
Опубликовано: (2007-07-01)

PDE10A antibodies in autoimmune encephalitis: a possible marker of cancer immunotherapy?
по: Titulaer, MJ, и др.
Опубликовано: (2019)

Antiganglioside antibodies and paraneoplastic neuromuscular junction disorder?
по: Noushin Jazebi, и др.
Опубликовано: (2020-12-01)

EARLY AND CONTINUED TREATMENT OF N-METHYL D-ASPARTATE RECEPTOR-ANTIBODY ENCEPHALITIS OPTIMISES OUTCOME OF A PREDOMINANTLY NON-PARANEOPLASTIC DISEASE
по: Irani, SR, и др.
Опубликовано: (2009)

An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes
по: Sai Wang, и др.
Опубликовано: (2023-01-01)

Anti-Ma2-antibody-associated encephalitis: An atypical paraneoplastic neurologic syndrome
по: Bogna Targonska, и др.
Опубликовано: (2018-05-01)

Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
по: Paul Gozzard, и др.
Опубликовано: (2015-01-01)

Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes
по: Daniel Chiu, и др.
Опубликовано: (2023-07-01)

Neurological manifestation of cancer – paraneoplastic syndromes
по: Szklener Katarzyna, и др.
Опубликовано: (2021-06-01)

Role of ion channel autoantibodies in NK-cell antibody-dependent anti-tumour immunity in patients with paraneoplastic Lambert-Eaton syndrome
по: Tschernatsch, M, и др.
Опубликовано: (2009)

Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies
по: Jonas Feldheim, и др.
Опубликовано: (2021-05-01)

Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study
по: Yi Guo, и др.
Опубликовано: (2021-11-01)

Antibody‐positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series
по: Sonja Kosek, и др.
Опубликовано: (2024-05-01)

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
по: Irani, S, и др.
Опубликовано: (2010)

Autoimmune and paraneoplastic seizures
по: Wagner, B, и др.
Опубликовано: (2024)

Paraneoplastic neurologic syndrome: A practical approach
по: Sudheeran Kannoth
Опубликовано: (2012-01-01)

Ovarian Teratoma-Related Paraneoplastic Neurological Syndromes
по: Jingfang Lin, и др.
Опубликовано: (2022-05-01)

Paraneoplastic neurological syndromes: clinical presentations and management
по: Michelle F. Devine, и др.
Опубликовано: (2021-01-01)

Predicting disability and mortality in CV2/CRMP5‐IgG associated paraneoplastic neurologic disorders
по: Sanem P. Uysal, и др.
Опубликовано: (2024-03-01)

A case of paraneoplastic neurological syndrome expressing dual antineuronal antibodies: Anti-hu and recoverin
по: Ho-Sung Ryu, и др.
Опубликовано: (2020-01-01)

P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.
по: Graus, F, и др.
Опубликовано: (2002)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
по: Becker, E, и др.
Опубликовано: (2012)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
по: Becker, E, и др.
Опубликовано: (2012)

Thymoma and paraneoplastic myasthenia gravis.
по: Marx, A, и др.
Опубликовано: (2010)

Clinical characteristics and immunotherapy response in paraneoplastic neurologic syndrome patients with increased number of high-risk antibodies
по: Gong Wang, и др.
Опубликовано: (2025-01-01)